Merck and Moderna on Wednesday announced the initiation of the late-stage trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy…
Trending
- Staged wrestling or war? India’s script in the arena, clever wrestlers but who landed the real blow? How did Pakistan win the match?
- Oklahoma Cardiologist Saves Passenger Having Heart Attack Mid-Flight
- Mexican Navy Ship Strikes Brooklyn Bridge in New York, Leaving Two Dead and Several Injured
- Mangoes in Summer: How Eating One Daily Benefits Your Health
- Beat the Heat Naturally: 10 Amazing Benefits of Sardai/Thandai in Summer
- China’s LandSpace Launches New Methane-Powered Rocket, Placing Six Satellites in Orbit
- WhatsApp Introduces AI-Powered Profile Photo and Group Icon Generation on iOS
- Moody’s Downgrades US Credit Rating, Raising Concerns for Trump’s Tax Plans and Global Markets
Company
Our Team
-
The Jago Times Media Group
Mr.Zahid Akhtar (Raja Zahid Khanzada)
Editor-in-Chief
Mrs.Salma Hashmi
Chairman Advisory Board
Dr.Nasreen Akhtar
President
Mr.Amir Makhani
Editor
Mr.Syed Fayyaz Hassan
Managing Director/Publisher
Mr.Raja Raheel Akhtar Khanzada
Director & Sales Circulation
Mr.Rehan Siddique
Director News
Minhaz Bashir
Editor Digital media
Muhammad Afzal Abbasi
Resident Editor, Gulf
Hasnain Abid Khanzada
Pakistan Editor
USA Head office:
2900 Hwy 121 N Bedford Texas 76021 Dallas/Fort Worth
Ph: +1 (682) 551-6500
Pakistan Head office:
M-36, M28 Mezzanine Floor,
Falak Naz Plaza, Shariah-e-Faisal Karachi
Ph: +923063287306
© 2025 TheJagotimes.com